Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma

Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma

Abstract Background The incidence of stage I and stage II lung adenocarcinoma (LUAD) is likely to increase with the introduction of annual screening programs for high-risk individuals. We aimed to identify a reliable prognostic signature with immune-related genes that can predict prognosis and help...

Full description

Bibliographic Details
Main Authors: Pancheng Wu, Yi Zheng, Yanyu Wang, Yadong Wang, Naixin Liang
Format: Article
Language:English
Published: BMC 2020-10-01
Series:Journal of Translational Medicine
Subjects:
Lung adenocarcinoma
Overall survival
Immune-related genes
Prognosis
Risk score
Online Access:http://link.springer.com/article/10.1186/s12967-020-02545-z

Similar Items

Similar Items